Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Yesterday, Nov. 5, 2013, 166 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $50.32 to $1,887,935,195.16. Highlighted Stocks Traded by Insiders: ICU Medical (ICUI) - FREE Research Report Kovalchik Michael T who is Director at ICU Medical sold 917 shares at $60.56 on Nov. 5, 2013. Following this transaction, the Director owned 3,784 shares meaning that the stake was reduced by 19.51% with the 917 share transaction. The shares most recently traded at $60.94, up $0.38, or 0.63% since the insider transaction. The average volume for ICU Medical has been 170,200 shares per day over the past 30 days. ICU Medical has a market cap of $904.4 million and is part of the health care sector and health services industry. Shares are up 0.74% year to date as of the close of trading on Tuesday. ICU Medical, Inc. engages in the development, manufacture, and sale of medical devices used in infusion therapy, oncology, and critical care applications. The company has a P/E ratio of 23.5. Currently there are 2 analysts that rate ICU Medical a buy, no analysts rate it a sell, and 3 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on ICUI - FREETheStreet Quant Ratings rates ICU Medical as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full ICU Medical Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.